Acceptability of a wearable neonatal device to monitor and treat jaundice for new born infants from a rural setting

Acceptability of a wearable real-time neonatal device to enable home monitoring and treatment of jaundice for new born infants from a rural setting

Jaundice is a common condition in newborn infants that if left untreated can leave them with long term brain dysfunction. Approximately 60% of term and 80% of preterm newborn infants develop jaundice within the first week of life.

Funding Body
Digital Health Institute
Award Value
Start Date
September 2018
End Date
September 2021
3 years
Phototherapy is an artificial light source and the first line of treatment for newborn infants with jaundice. Developments in phototherapy point towards the possibility of providing home phototherapy services in the future. The recent creation of a ‘photonic textile’ could potentially be used as a wearable device to deliver phototherapy treatment at home. However, there is little or no research into the parent’s and health care professional’s views of the acceptability of this technology for phototherapy treatments being provided at home and to determine if this technology could have potential in future neonatal care.
Using qualitative methodology this study will aim to collect data on parents’ and healthcare professionals’ perspectives on the acceptability of a wearable device to provide home phototherapy for newborn infants a rural setting. Purposive sampling will be employed to recruit ten eligible parents for interview and 12-24 health care to participate in three focus groups. Analysis will be thematic in nature, using Nvivo for data management.

Cookie Consent